COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
Description
Data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients at early stage of immune reconstitution after hematopoietic stem cell transplantation (HSCT) are limited. In the present study, we retrospectively investigated
